Form 4: Arteris Director Antonio Viana Sells 40,000 Shares

Director Antonio J. Viana sold 40,000 shares of Arteris, Inc. common stock via a pre-arranged 10b5-1 trading plan.

Summary

• Director Antonio J. Viana executed the sale of 40,000 shares of Arteris, Inc. (AIP) common stock.
• The transactions occurred on May 13 and May 14, 2026.
• All sales were conducted through the Viana Family Trust.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on June 10, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sales were executed under a pre-planned 10b5-1 arrangement, which is a routine method for insider liquidity.

Positives

• The sale was conducted under a pre-established 10b5-1 trading plan, indicating the transactions were planned well in advance rather than reactive to immediate news.

Negatives

• Director divestment of 40,000 shares reduces the insider's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal of management's view on current valuation.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard corporate governance practice for liquidity and diversification, and is generally viewed as neutral unless the volume represents a significant portion of the insider's total holdings.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for directors to sell shares while avoiding potential insider trading allegations.

Stakeholder Impact

• Shareholders should note the reduction in insider ownership, though the pre-planned nature mitigates concerns regarding negative sentiment.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

Arteris, AIP, Insider Trading, Form 4, Director Sale, 10b5-1